Holen Sie sich die Stockscreener-App
43.55
2.84%
-1.275
Handel nachbörslich:
43.57
0.015
+0.03%
Schlusskurs vom Vortag:
$44.83
Offen:
$44.96
24-Stunden-Volumen:
324.29K
Relative Volume:
0.81
Marktkapitalisierung:
$2.05B
Einnahmen:
$384.90M
Nettoeinkommen (Verlust:
$-851.00K
KGV:
-2,177.75
EPS:
-0.02
Netto-Cashflow:
$12.83M
1W Leistung:
+1.65%
1M Leistung:
+38.71%
6M Leistung:
+70.40%
1J Leistung:
+66.11%
1-Tages-Spanne:
$43.47
$45.02
1-Wochen-Bereich:
$41.60
$45.07
52-Wochen-Spanne:
$21.97
$45.07
Artivion Inc Stock (AORT) Company Profile
Firmenname
Artivion Inc
Sektor
Branche
Telefon
(770) 419-3355
Adresse
1655 ROBERTS BOULEVARD N W, KENNESAW
Vergleichen Sie AORT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
43.53 | 2.02B | 384.90M | -851.00K | 12.83M | -0.02 |
|
ABT
Abbott Laboratories
|
131.87 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.11 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
390.88 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.02 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.88 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-27 | Bestätigt | Lake Street | Buy |
| 2022-08-08 | Eingeleitet | Lake Street | Buy |
| 2022-03-03 | Eingeleitet | Stifel | Buy |
Alle ansehen
Artivion Inc Aktie (AORT) Neueste Nachrichten
Artivion Inc. Inches Above Key Support — Safe to HoldRate Cut & Short-Term Trading Alerts - thegnnews.com
Artivion's Insider Transactions: A Governance and Liquidity Lens into Q2 2025 Performance - AInvest
Artivion CEO Mackin sells $528k in shares - Investing.com
Artivion price target raised to $41 from $35 at Canaccord - MSN
Artivion Inc. Building a Base Near SupportWeekly Investment Summary & AI Powered Market Trend Analysis - beatles.ru
Price Floor Holding on Artivion Inc. — Rebound PossibleWeekly Profit Recap & Community Verified Trade Signals - metrotimes.co.kr
Can Artivion Inc. ride the EV wave2025 Volume Leaders & Free Expert Verified Stock Movement Alerts - newsyoung.net
Is Artivion Inc. stock heavily shortedJuly 2025 News Drivers & Real-Time Volume Trigger Notifications - newsyoung.net
Reversal Confirmed Artivion Inc. Stock Rallies Above MAJuly 2025 Short Interest & Daily Profit Maximizing Tips - newsimpact.co.kr
Artivion's Strong Financials and Promising Pipeline Justify Buy Rating - AInvest
Real Time Chart Alerts Flash Bullish on Artivion Inc.Forecast Cut & Safe Capital Growth Tips - sundaytimes.kr
Artivion Inc. Attempts Reversal From Key SupportGDP Growth & AI Driven Price Predictions - classian.co.kr
Artivion SVP Holloway sells $1m in shares after option exercise - Investing.com
Artivion’s chief commercial officer Davis sells $471k in shares - Investing.com
Artivion’s chief commercial officer Davis sells $471k in shares By Investing.com - Investing.com UK
Artivion Insider Sold Shares Worth $471,756, According to a Recent SEC Filing - MarketScreener
Chart based analysis of Artivion Inc. trends2025 Institutional Moves & Growth Focused Investment Plans - Newser
Earnings visualization tools for Artivion Inc.Weekly Volume Report & AI Driven Price Forecasts - Newser
Will Artivion Inc. stock benefit from interest rate changesPortfolio Value Summary & Daily Volume Surge Signals - Newser
Artivion stock hits 52-week high at 43.93 USD - Investing.com
Artivion stock hits 52-week high at 43.93 USD By Investing.com - Investing.com Canada
Artivion at Canaccord Conference: Strategic Growth and Innovation - Investing.com
Artivion at Canaccord Conference: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria
Is this a good reentry point in Artivion Inc.July 2025 Action & Daily Growth Stock Investment Tips - Newser
Artivion, Inc. (NYSE:AORT) Stock Holdings Lifted by Natixis Advisors LLC - Defense World
Artivion's (AORT) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Is now a turning point for Artivion Inc.IPO Watch & AI Driven Stock Reports - Newser
Revenues Tell The Story For Artivion, Inc. (NYSE:AORT) As Its Stock Soars 37% - simplywall.st
Artivion, Inc. (NYSE:AORT) Q2 2025 Earnings Call Transcript - Insider Monkey
Technical signs of recovery in Artivion Inc.Reversal Signal Prediction Based on Volume - Newser
Artivion Inc. Reports Strong Q2 Earnings and Positive Outlook - TipRanks
Artivion Appoints Lance Berry as COO, Raises Earnings Guidance - AInvest
Artivion Appoints Lance Berry as COO - MarketScreener
Artivion Appoints Lance A. Berry as COO - TipRanks
Artivion Reaches Analyst Target Price - Nasdaq
Artivion Surges on Improved 2025 Financial Outlook - StocksToTrade
Artivion’s Stocks Surge as Q2 Financials Exceed Expectations - timothysykes.com
Artivion (NYSE:AORT) Earns “Buy” Rating from Needham & Company LLC - Defense World
Canaccord Genuity Group Forecasts Strong Price Appreciation for Artivion (NYSE:AORT) Stock - Defense World
What technical models suggest about Artivion Inc.’s comebackPredictive Short-Term Market Reversal Alerts - Newser
Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth - MSN
Artivion's Q2 Earnings Surge: A High-Margin Medical Innovation Play with Undervalued Potential - AInvest
Artivion, Inc.'s (NYSE:AORT) 26% Jump Shows Its Popularity With Investors - 富途牛牛
Artivion price target raised to $45 from $32 at Needham - Yahoo Finance
Artivion Second Quarter 2025 Earnings: Beats Expectations - uk.finance.yahoo.com
Artivion Elevates 2025 Revenue Projection Amid Strong Q2 Earnings - StocksToTrade
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $40 to $45 - 富途牛牛
Artivion 2025 Q2 Earnings Strong Performance with Net Income Surges 163% - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Raises Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (NYSE:AORT) Shares Gap Up on Better-Than-Expected Earnings - Defense World
Artivion (NYSE:AORT) Stock Rating Upgraded by Wall Street Zen - Defense World
Finanzdaten der Artivion Inc-Aktie (AORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):